SIGA Technologies Inc (SIGA)
7.00
-0.21
(-2.91%)
USD |
NASDAQ |
Nov 04, 16:00
6.99
-0.01
(-0.14%)
After-Hours: 20:00
SIGA Technologies Enterprise Value: 392.64M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 392.64M |
| November 01, 2024 | 407.62M |
| October 31, 2024 | 408.34M |
| October 30, 2024 | 398.34M |
| October 29, 2024 | 400.49M |
| October 28, 2024 | 394.06M |
| October 25, 2024 | 376.22M |
| October 24, 2024 | 363.37M |
| October 23, 2024 | 364.80M |
| October 22, 2024 | 367.66M |
| October 21, 2024 | 384.07M |
| October 18, 2024 | 386.93M |
| October 17, 2024 | 397.63M |
| October 16, 2024 | 378.36M |
| October 15, 2024 | 374.08M |
| October 14, 2024 | 374.79M |
| October 11, 2024 | 383.36M |
| October 10, 2024 | 364.09M |
| October 09, 2024 | 359.81M |
| October 08, 2024 | 369.08M |
| October 07, 2024 | 384.07M |
| October 04, 2024 | 391.21M |
| October 03, 2024 | 389.78M |
| October 02, 2024 | 386.93M |
| October 01, 2024 | 390.49M |
| Date | Value |
|---|---|
| September 30, 2024 | 374.79M |
| September 27, 2024 | 389.78M |
| September 26, 2024 | 388.35M |
| September 25, 2024 | 374.79M |
| September 24, 2024 | 464.72M |
| September 23, 2024 | 494.69M |
| September 20, 2024 | 494.69M |
| September 19, 2024 | 501.83M |
| September 18, 2024 | 461.86M |
| September 17, 2024 | 455.44M |
| September 16, 2024 | 463.29M |
| September 13, 2024 | 456.87M |
| September 12, 2024 | 454.73M |
| September 11, 2024 | 429.03M |
| September 10, 2024 | 431.89M |
| September 09, 2024 | 461.86M |
| September 06, 2024 | 443.31M |
| September 05, 2024 | 461.86M |
| September 04, 2024 | 453.30M |
| September 03, 2024 | 444.02M |
| August 30, 2024 | 537.52M |
| August 29, 2024 | 548.22M |
| August 28, 2024 | 550.36M |
| August 27, 2024 | 558.93M |
| August 26, 2024 | 564.64M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
170.48M
Minimum
Feb 05 2024
1.795B
Maximum
Aug 15 2022
438.18M
Average
407.25M
Median
Jul 06 2020
Enterprise Value Benchmarks
| Emergent BioSolutions Inc | 1.256B |
| Chimerix Inc | -59.43M |
| Geovax Labs Inc | 8.055M |
| Abbott Laboratories | 211.48B |
| Tonix Pharmaceuticals Holding Corp | 7.452M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 1.833M |
| Revenue (Quarterly) | 21.81M |
| Total Expenses (Quarterly) | 20.73M |
| EPS Diluted (Quarterly) | 0.03 |
| Gross Profit Margin (Quarterly) | 30.31% |
| Profit Margin (Quarterly) | 8.40% |
| Earnings Yield | 16.71% |
| Operating Earnings Yield | 20.47% |
| Normalized Earnings Yield | 16.71 |